Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Ocmr scans

Since our foundation in 2001, we have performed over 42,000 scans. This includes over 12,000 research scans and nearly 30,000 heart scans for NHS and private patients.

Researchers at OCMR have had great success in attracting external funding from grant bodies including the British Heart Foundation (BHF), Medical Research Council (MRC), Wellcome Trust and the National Institute for Health Research (NIHR). Our total project-specific grant funding is in excess of £26M.

Publications and Impact:OCMR Publications

OCMR have published over 600 peer reviewed papers and manuscripts, many in high impact journals. The mean impact factor of papers published in 2016 was 8.3. There were 5 publications in journals with an impact factor above 17. We estimate that the work of OCMR has been cited >14,000 times, with an average of more than one citation per day over the last ten years. 

Investigator Awards:

OCMR provides a strong supportive atmosphere to nurture new researchers, our researchers have achieved 35 Young Investigator Awards since 2004.

The future

We are a growing unit. In 2015, with the support of an infrastructure grant from the British Heart Foundation (BHF) we added an extra floor to our building to increase research and teaching space. In 2017, again with the assistance of an infrastructure grant from BHF we installed a third MRI scanner to enable us to expand our research capacity. We have also recently created an imaging core lab which provides an image analysis service for multicentre studies. Our future research themes will include:

  • Continue proof-of-principle studies and MR physics development, eg 13C-Hyperpolarizer, 7T clinical application, Parametric mapping, DTI, 4D flow, Other organs –Liver, spleen.
  • Image analysis group/core lab
  • Lead/co-lead large-scale multicentre clinical trials
  • Build on HCMR (an international registry of 44 sites to study 2750 HCM patients, to change the paradigm of risk stratification, using CMR, genetic and biomarker analyses). Extend follow up to 10 years, imaging repeat.
  • Imaging for large scale population studies, eg UK Biobank/Big Data Institute